维普中文期刊产品整合服务

CD28/CTLA-4/B7 and CD40/CD40L costimulation and activation of regulatory T cells

查看全文 作  者:Isabel T [1]Vogel;Stefaan W Van [1,2]Gool;Jan L [1]Ceuppens 高影响力作者 机构地区:[1]Laboratory of Clinical Immunology, Department of Microbiology and Immunology, KU Leuven, University Hospital Gasthuisberg;[2]Laboratory of Pediatric Immunology, KU Leuven, University Hospital Gasthuisberg高影响力机构 出  处:《World Journal of Immunology》索引2014年第4卷第2期,共15页高影响力期刊 摘  要:Costimulatory signals are crucial for T cell activation. Attempts to block costimulatory pathways have been effective in preventing unwanted immune reactions. In particular, blocking the CD28/cytotoxic T lymphocyte antigen(CTLA)-4/B7 interaction(using CTLA-4Ig) and the CD40/CD40 L interaction(using anti-CD40 L antibodies) prevents T cell mediated autoimmune diseases, transplant rejection and graft vs host disease in experimental models. Moreover, CTLA-4Ig is in clinical use to treat rheumatoid arthritis(abatacept) and to prevent rejection of renal transplants(belatacept). Under certain experimental conditions, this treatment can even result in tolerance. Surprisingly, the underlying mechanisms of immune modulation are still not completely understood. We here discuss the evidence that costimulation blockade differentially affects effector T cells(Teff) and regulatory T cells(Treg). The latter are required to control inappropriate and unwanted immune responses, and their activity often contributes to tolerance induction and maintenance. Unfortunately, our knowledge on the costimulatory requirements of Treg cells is very limited. We therefore summarize the current understanding ofthe costimulatory requirements of Treg cells, and elaborate on the effect of anti-CD40 L antibody and CTLA-4Ig treatment on Treg cell activity. In this context, we point out that the outcome of a treatment aiming at blocking the CD28/CTLA-4/B7 costimulatory interaction can vary with dosing, timing and underlying immunopathology. 关 键 词:Regulatory T cells Tolerance CYTOTOXIC T LYMPHOCYTE antigen-4Ig Anti-CD40L COSTIMULATION
相关文献

参考文献(169)

引证文献(3)

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费